Calcitonin Stewardship Strategies-Reference-Cited by-同舟云学术

Calcitonin Stewardship Strategies

Published:2018-04-16 Issue:5 Volume:32 Page:584-585
ISSN:0897-1900
Container-title:Journal of Pharmacy Practice
language:en
Short-container-title:Journal of Pharmacy Practice

Author:

Allison Steven L.¹,Davis Kevin W.²

Affiliation:

1. Executive Director of Pharmacy, Florida Hospital, Orlando, FL, USA

2. Inpatient Operations Supervisor, University of Florida Health Jacksonville, Jacksonville, FL, USA

Abstract

Despite being approved by the Food and Drug Administration for over 30 years, calcitonin salmon has seen a dramatic increase in acquisition cost over the last few years. Being commonly used for the treatment of hypercalcemia of malignancy, health systems must implement stewardship strategies in order to curtail usage. This review is intended to provide a background on calcitonin usage for hypercalcemia of malignancy and associated strategies to ensure appropriateness of utilization within health systems.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/0897190018770052

Reference7 articles.

1. Prevalence of hypercalcemia among cancer patients in the United States

2. Evidence for Calcitonin—A New Hormone from the Parathyroid That Lowers Blood Calcium

3. The NORC at the University of Chicago, “Trends in Hospital Inpatient Drug Costs: Issues and Challenges,” October 11, 2016; accessed at: http://www.aha.org/content/16/aha-fah-rx-report.pdf.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a Pharmacy-Driven Calcitonin Protocol for Treating Hypercalcemia in Hospitalized Patients: A Multisite Study;Journal of Pharmacy Practice;2021-05-06

2. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics;AAPS PharmSciTech;2020-11-19